Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,318 | 65 | 88.8% |
| Education | $166.54 | 5 | 11.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Antares Pharma, Inc. | $358.67 | 23 | $0 (2024) |
| Astellas Pharma US Inc | $311.64 | 16 | $0 (2022) |
| COLOPLAST CORP | $144.11 | 1 | $0 (2024) |
| Boston Scientific Corporation | $129.37 | 1 | $0 (2021) |
| Gilead Sciences, Inc. | $74.32 | 1 | $0 (2020) |
| Clarus Therapeutics Inc. | $69.88 | 5 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $64.31 | 4 | $0 (2023) |
| Teleflex LLC | $54.46 | 2 | $0 (2021) |
| ABBVIE INC. | $45.23 | 3 | $0 (2024) |
| DENTSPLY IH AB | $44.46 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $402.13 | 15 | COLOPLAST CORP ($144.11) |
| 2023 | $176.04 | 11 | Antares Pharma, Inc. ($111.73) |
| 2022 | $260.44 | 14 | Antares Pharma, Inc. ($120.61) |
| 2021 | $408.78 | 18 | Boston Scientific Corporation ($129.37) |
| 2020 | $74.32 | 1 | Gilead Sciences, Inc. ($74.32) |
| 2019 | $148.17 | 8 | Astellas Pharma US Inc ($148.17) |
| 2018 | $12.25 | 1 | NeoTract Inc. ($12.25) |
| 2017 | $2.62 | 2 | Retrophin, Inc. ($2.62) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/31/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: UROLOGY | ||||||
| 10/09/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $44.46 | General |
| Category: Medical Urology | ||||||
| 09/10/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 08/14/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: UROTHELIAL CANCER | ||||||
| 07/23/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: UROTHELIAL CANCER | ||||||
| 07/09/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/25/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/26/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 03/07/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/02/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 01/24/2024 | COLOPLAST CORP | — | Food and Beverage | In-kind items and services | $144.11 | General |
| 10/20/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/12/2023 | Supernus Pharmaceuticals, Inc. | TLANDO (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/08/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/27/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 05/15/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 04/14/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 03/24/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 03/10/2023 | Antares Pharma, Inc. | XYOSTED (Drug), TLANDO, NOCDURNA | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 02/03/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 01/27/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 363 | 496 | $147,865 | $42,273 |
| 2022 | 10 | 533 | 689 | $117,455 | $26,676 |
| 2021 | 13 | 727 | 1,043 | $220,360 | $56,431 |
| 2020 | 13 | 786 | 1,142 | $256,795 | $58,421 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 81 | 93 | $34,965 | $13,923 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 84 | $33,160 | $9,074 | 27.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 46 | 130 | $26,000 | $8,882 | 34.2% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 54 | 67 | $10,525 | $2,807 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 37 | $12,425 | $2,672 | 21.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $5,500 | $1,764 | 32.1% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 11 | 12 | $18,180 | $1,463 | 8.0% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 24 | 25 | $5,750 | $1,352 | 23.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 19 | 20 | $1,030 | $202.60 | 19.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 16 | 16 | $330.00 | $134.40 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 135 | $48,600 | $11,884 | 24.5% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2022 | 93 | 136 | $25,160 | $4,939 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 65 | $15,925 | $4,317 | 27.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $7,150 | $1,644 | 23.0% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2022 | 32 | 35 | $7,875 | $1,535 | 19.5% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2022 | 13 | 14 | $6,510 | $1,455 | 22.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 109 | 138 | $2,070 | $304.55 | 14.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 57 | 72 | $1,800 | $246.36 | 13.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 21 | 23 | $1,495 | $181.46 | 12.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 48 | 58 | $870.00 | $169.29 | 19.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 108 | 161 | $57,960 | $16,463 | 28.4% |
| 76857 | Ultrasound of pelvis, limited, not pregnancy related | Office | 2021 | 118 | 173 | $32,005 | $6,910 | 21.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 31 | 35 | $23,275 | $6,140 | 26.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 66 | 81 | $19,845 | $5,512 | 27.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 23 | 31 | $14,880 | $4,410 | 29.6% |
About Dr. Sean Egan, M.D
Dr. Sean Egan, M.D is a Urology healthcare provider based in West Orange, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164588711.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sean Egan, M.D has received a total of $1,485 in payments from pharmaceutical and medical device companies, with $402.13 received in 2024. These payments were reported across 70 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,318).
As a Medicare-enrolled provider, Egan has provided services to 2,409 Medicare beneficiaries, totaling 3,370 services with total Medicare billing of $183,801. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location West Orange, NJ
- Active Since 12/28/2006
- Last Updated 05/06/2009
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1164588711
Products in Payments
- NOCDURNA (Drug) $245.75
- XYOSTED (Drug) $160.02
- MYRBETRIQ (Drug) $131.33
- GENERAL KIDNEY STONE DISEASE (Device) $129.37
- Descovy (Drug) $74.32
- JATENZO (Drug) $69.88
- UroLift System (Device) $54.46
- GEMTESA (Drug) $46.76
- LUPRON DEPOT (Drug) $45.23
- LOFRIC (Device) $44.46
- JELMYTO (Drug) $34.95
- ERLEADA (Drug) $28.48
- Xtandi (Drug) $28.41
- ORGOVYX (Drug) $23.93
- Axonics (Device) $21.07
- ILLUCCIX (Drug) $18.24
- TLANDO (Drug) $17.21
- UroLift (Device) $12.25
- Myrbetriq (Drug) $11.91
- (815) Thiola (Drug) $2.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in West Orange
Louis Galdieri, Md, MD
Urology — Payments: $11,881
Todd Linsenmeyer, M.d, M.D
Urology — Payments: $7,932
Dr. George Johnson, M.d, M.D
Urology — Payments: $3,994
Dr. Matthew Whang, Md, MD
Urology — Payments: $3,716
Bruce Lefkon, Md, MD
Urology — Payments: $843.92
Dr. Ronald Frank, M.d, M.D
Urology — Payments: $142.47